Behavioral
PROSPECT
PROSPECT is a behavioral intervention with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
BEHAVIORAL
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Terminated(1)
Detailed Status
Recruiting1
Completed1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
50.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
recruiting133%
completed133%
terminated133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingnot_applicable
PROficiency Based StePwise Endovascular Curricular Training: Multicentric Registry
NCT05620186
terminatednot_applicable
Prospective Study Evaluating the Use of PROSPECT to Reduce Insomnia in Patients With Early Stage Breast Cancer
NCT02712437
completednot_applicable
Initial Assessment of an Internet-based Symptom Management Intervention in Early Stage Breast Cancer
NCT02495155
Clinical Trials (3)
Showing 3 of 3 trials
NCT05620186Not Applicable
PROficiency Based StePwise Endovascular Curricular Training: Multicentric Registry
NCT02712437Not Applicable
Prospective Study Evaluating the Use of PROSPECT to Reduce Insomnia in Patients With Early Stage Breast Cancer
NCT02495155Not Applicable
Initial Assessment of an Internet-based Symptom Management Intervention in Early Stage Breast Cancer
All 3 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 3